61755-001 : Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: | 61755-001 |
Labeler: | Regeneron Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Arcalyst |
Dosage Form: | Subcutaneous Injection, Powder, Lyophilized, for Solution |
Application #: | BLA125249 |
Rev. Date: |
NDC Package Codes:
- 61755-001-01: 4 VIAL, SINGLE‑USE IN 1 CARTON (61755‑001‑01) > 2 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Rilonacept
Dosage Strength:
- 160 mg/2mL
Related Products:
Based on records with the same trade name.- 73604-914 Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Kiniksa Pharmaceuticals (Uk), Ltd.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 61752-001Next: 61755-005 >
Related Discussions:
Rilonacept
Clinical trial for gout treatment. Is it safe? Who has been on it for any reason and what did they think of it?...
Clinical trial for gout treatment. Is it safe? Who has been on it for any reason and what did they think of it?...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.